All In Biotech

Free tool

FAERS Monitor: Omegaven

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210589 or its brand name (Omegaven, Fish Oil Triglycerides). Reports on generic versions are filed under their own applications.

Reports

91,003

Serious

44,188

49% of reports

Hospitalization

19,259

Death reported

4,595

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue8,464
  • drug ineffective6,296
  • diarrhoea6,166
  • nausea6,153
  • headache5,875
  • pain5,511
  • dizziness4,883
  • arthralgia4,717
  • pruritus4,449
  • dyspnoea4,445
  • asthenia4,179
  • rash3,943
  • off label use3,900
  • vomiting3,405
  • pain in extremity3,398

Reports by year received

View as table
YearReports
2004221
2005296
2006331
2007552
20081,128
20092,089
20103,308
20113,404
20124,433
20134,921
20145,081
20157,791
20168,130
20176,889
20186,407
20195,620
20205,184
20214,412
20224,751
20234,222
20244,434
20254,205
20263,193

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,963,156 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pruritusSignal4,4492.72.64,775
pain in extremitySignal3,3982.72.63,600
arthralgiaSignal4,7172.62.64,848
astheniaSignal4,1792.62.54,093
fatigueSignal8,4642.52.58,037
dizzinessSignal4,8832.32.23,538
diarrhoeaSignal6,1662.22.24,220
headacheSignal5,8752.22.13,815
rashSignal3,9432.12.02,300
painSignal5,5112.12.03,168
dyspnoea4,4451.81.81,677
nausea6,1531.81.82,268
vomiting3,4051.71.6948
drug ineffective6,2961.11.166
off label use3,9001.01.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.